GUSELKUMAB

IL-23 Inhibitors for Psoriasis Therapeutic Cheat Sheet
IL-23 Inhibitors
by Blair Allais, MD on
Psoriasis involves a complex inflammatory cascade mediated by various cytokine effectors. Over the past fifteen years, treatment options have evolved to include biologic medications that provide targeted inhibition of various pathways. IL-23 has emerged as an important inflammatory cytokine in the pathogenesis of psoriasis. We continue our series, Therapeutic Cheat Sheet, with a closer look at IL- …
JDD August Issue Highlights
by NEXT STEPS IN DERM TEAM on
Here are the issue highlights for the JDD August issue with special focus on Psoriasis: Authors discuss the epidemiological, clinical, and histologic features of melasma and postinflammatory hyperpigmentation and important considerations for both established and emerging treatments in Therapeutic Insights in Melasma and Hyperpigmentation Management (CE credit is available)   Descriptive char …